Table 1. Clinical characteristics of the study population.
| Characteristic | Value (n = 61) |
|---|---|
| Mean age at diagnosis, years (range) | 66.8 (35.1–81.6) |
| Gravidity (median) | 4 |
| Parity (median) | 4 |
| BMI (kg/m2) | |
| Mean (range) | 32.9 (20.6–56.2) |
| Menopausal status | No (%) |
| Premenopausal | 2 (3.3) |
| Postmenopausal | 59 (96.7) |
| Presenting complaint * | |
| Abnormal uterine bleeding | 55 (90.2) |
| Pain | 16 (26.2) |
| Loss of weight | 13 (21.3) |
| Abnormal discharge | 9 (14.8) |
| Other | 9 (14.8) |
| Comorbid diseases * | |
| Hypertension | 52 (85.3) |
| Diabetes | 20 (32.8) |
| Osteoarthritis | 7 (11.5) |
| Ischemic heart disease | 6 (9.8) |
| Hypercholesterolemia | 6 (9.8) |
| History of breast cancer | 4 (6.6) |
| Other | 11 (18) |
| Family history of cancer # | |
| Yes | 11 (18.03) |
| No | 49 (80.33) |
| Unknown | 1 (1.64) |
| Cervical smear results | |
| Result not available | 17 (27.9) |
| Unsuitable for interpretation | 2 (3.3) |
| Normal | 13 (21.3) |
| Abnormal | 29 (47.6) |
| Pre-operative biopsy results | |
| Suggestive of carcinosarcoma | 32 (52.5) |
| Suggestive of other malignancy or poorly differentiated tumour | 22 (36.1) |
| Not done/unsuitable for diagnosis | 7 (11.5) |
| FIGO Stage presentation | |
| FIGO I | 18 (29.5) |
| FIGO II | 5 (8.2) |
| FIGO III | 16 (26.2) |
| FIGO IV | 22 (36.1) |
| Five-year progression-free survival | 17.3% (CI 8.9%-27.9%) |
| Overall 5-year survival | 19.7% (CI 10.6%-30.8%) |
*Some patients presented with a combination of factors.
#First degree relative only of any cancer.